Immuno Cure appoints new CFO
- Written by PR Newswire
Strengthening of executive management team to propel growth strategy
HONG KONG, Nov. 1, 2022 /PRNewswire/ -- Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the appointment of Mr Mark LO Chun Bun as Chief Financial Officer of the...
